SEC 13F Intelligence

Frazier Management LLC / TARS

Frazier Management LLC’s Tarsus Pharmaceuticals Inc Position

Does Frazier Management LLC own Tarsus Pharmaceuticals Inc (TARS)? Not currently — the last reported position was 1.42M shares worth $32M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$32M
Q4 2021
Shares
1.42M
% of Portfolio
+2.45%
Quarters Held
5
position exited

Position History TARS

Reported value by quarter
Q4 ’20: $79MQ4 ’20Q1 ’21: $62MQ1 ’21Q2 ’21: $41MQ2 ’21Q3 ’21: $31MQ3 ’21Q4 ’21: $32MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20211.42M$32M+2.45%
Q3 20211.42M$31M+2.44%
Q2 20211.42M$41M+3.79%
Q1 20211.92M$62M+4.96%
Q4 20201.92M$79M+6.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of TARS.